相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study
Jason Fangusaro et al.
NEURO-ONCOLOGY (2021)
Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species
B. D. van Groen et al.
PHARMACOLOGICAL REVIEWS (2021)
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network
Zahari Vinarov et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Quantification of P-Glycoprotein in the Gastrointestinal Tract of Humans and Rodents: Methodology, Gut Region, Sex, and Species Matter
Yang Mai et al.
MOLECULAR PHARMACEUTICS (2021)
Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
Liang Huang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
Impact of gastrointestinal physiology on drug absorption in special populations – An UNGAP review
Cordula Stillhart et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition
Liana Nobre et al.
JCO PRECISION ONCOLOGY (2020)
Metronomic Maintenance for High-Risk Pediatric Malignancies: One Size Will Not Fit All
Nicolas Andre et al.
TRENDS IN CANCER (2020)
Management of pediatric low-grade glioma
Peter de Blank et al.
CURRENT OPINION IN PEDIATRICS (2019)
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial
Gianni Bisogno et al.
LANCET ONCOLOGY (2019)
A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer
Yunpeng Yang et al.
JOURNAL OF THORACIC DISEASE (2019)
Pediatric low-grade gliomas: next biologically driven steps
David T. W. Jones et al.
NEURO-ONCOLOGY (2018)
Paediatric gliomas: diagnosis, molecular biology and management
Alexandros Blionas et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Oral drug absorption in pediatrics: the intestinal wall, its developmental changes and current tools for predictions
Jean-Marie Nicolas et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Cellular and molecular effects of metronomic vinorelbine and 4-O-deacetylvinorelbine on human umbilical vein endothelial cells
Eirini Biziota et al.
ANTI-CANCER DRUGS (2016)
Epidemiology of Brain Tumors
Katharine A. McNeill
NEUROLOGIC CLINICS (2016)
Considering Age Variation When Coining Drugs as High versus Low Hepatic Extraction Ratio
Farzaneh Salem et al.
DRUG METABOLISM AND DISPOSITION (2016)
Single agent vinorelbine in pediatric patients with progressive optic pathway glioma
Andrea Maria Cappellano et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Metronomics: towards personalized chemotherapy?
Nicolas Andre et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution
C. Colin et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
Ariel R. Topletz et al.
DRUG METABOLISM AND DISPOSITION (2013)
Vinorelbine in Cancer Therapy
Anna Capasso
CURRENT DRUG TARGETS (2012)
Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: Good tolerance profile and efficacy in rhabdomyosarcoma - A report from the Societe Francaise des Cancers et leucemies de l'Enfant et de l'adolescent (SFCE)
Veronique Minard-Colin et al.
EUROPEAN JOURNAL OF CANCER (2012)
P-Glycoprotein, Multidrug-Resistance Associated Protein 2, Cyp3a, and Carboxylesterase Affect the Oral Availability and Metabolism of Vinorelbine
Jurjen S. Lagas et al.
MOLECULAR PHARMACOLOGY (2012)
Rapid and sensitive determination of vinorelbine in human plasma by liquid chromatography-tandem mass spectrometry and its pharmacokinetic application
Jun Qian et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Vinorelbine in progressive unresectable low-grade glioma in children.
A. M. Cappellano et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase I Study of Vorinostat in Patients With Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
Suresh S. Ramalingam et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine
Jame Abraham et al.
CLINICAL CANCER RESEARCH (2009)
Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
Evangelos Briasoulis et al.
CLINICAL CANCER RESEARCH (2009)
Pediatric Low-Grade Gliomas
Angela J. Sievert et al.
JOURNAL OF CHILD NEUROLOGY (2009)
New Equations to Estimate GFR in Children with CKD
George J. Schwartz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Essentials for starting a pediatric clinical study (1): Pharmacokinetics in children
Tsuyoshi Yokoi
JOURNAL OF TOXICOLOGICAL SCIENCES (2009)
Metabolism pathway of vinorelbine (Navelbine®) in human:: Characterisation of the metabolites by HPLC-MS/MS
J. de Graeve et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
A high performance liquid chromatography method for vinorelbine and 4-O-deacetyl vinorelbine:: A decade of routine analysis in human blood
C. Puozzo et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients
Walter J. Loos et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer
Mark Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice
RR Press et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: A report from the children's oncology group
M Johansen et al.
CLINICAL CANCER RESEARCH (2006)
Considerations on the role of chemotherapy and modern radiotherapy in the treatment of childhood low grade glioma
G Perilongo
JOURNAL OF NEURO-ONCOLOGY (2005)
Changes in liver volume from birth to adulthood: A meta-analysis
TN Johnson et al.
LIVER TRANSPLANTATION (2005)
Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age
M Fakhoury et al.
DRUG METABOLISM AND DISPOSITION (2005)
Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes:: A comparative analysis in paired tissue specimens
O von Richter et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer
R Deporte-Fety et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Pharmacokinetic linearity of i.v. vinorelbine from an intra-patient dose escalation study design
D Khayat et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine
P Variol et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from phase I clinical trials
L Nguyen et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer
A Gauvin et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
分享论文
